PROCOMB trial ( ISRCTN78639965 ) was a randomized double-blinded , double-dummy multicenter study of 225 patients between 55 and 80 years old , PSA4ng/ml , IPSS 12 , prostate volume 60 cc , Qmax 15ml/sec , postvoid residual urine ( PVR ) < 150ml .